Cointime

Denali Ventures

investment firm

About

Denali Ventures, an investment firm, finances companies with methods for controlling significant disease entities and medical conditions.

  • Herzliya,Tel Aviv,Israel

Highlights

Investments
6
Exits
3
Employee Profiles
3

Details

Founded date
Jan 1, 1998
Operating Status
Active
Investor Type
Venture Capital

Investments

Number of Investments
Number of Lead Investments
6
0
Denali Ventures has made 6 investments. Their most recent investment was on May 20, 2016, when Fanplayr raised $6M.
Date Company Name
Round Money Raised Industry Lead Investor
May 20, 2016 Fanplayr
Series A $6M Ad Targeting —
May 15, 2012 Gamida Cell
Series E $10M Biotechnology —
Sep 27, 2006 Gamida Cell
Series D $16M Biotechnology —
Oct 3, 2002 HyperRoll
Series B $12.50M Architecture —
Oct 16, 2001 D Pharm LTD.
Series D $30M Biopharma —
Show More

Employee Profiles

Number of Employee Profiles
3
Denali Ventures has 3 current employee profiles, including Executive Noam Karstaedt
Noam Karstaedt
Executive
Ronny Ginor
Executive
Yael Margolin
Board member

Exits

Denali Ventures has had 3 exits. Denali Ventures most notable exits include Gamida Cell ,   HyperRoll

Date Company Name Exit Type Industry
Oct 25, 2018 Gamida Cell IPO Biotechnology Detail
Sep 29, 2009 HyperRoll M&A Architecture Detail
Aug 17, 2009 D Pharm LTD. IPO Biopharma Detail
Cointime
İçerikler
Şirket.